Citric acid and compound citric acid application in pharmacy

Abstract

The invention relates to a new usage of citric acid and compound citric acid in the field of pharmacy. The product can prevent and control viral diseases and bacterial diseases of livestock and poultry; wherein, the compound citric acid comprises the following components according to weight portion: 93-98 portions of citric acid, 0.5-4 portions of gualfenesin and 1.5-3 portions of etamsylate. Proved by in vivo and vitro experiments, the compound citric acid can play a role in preventing and controlling fowl mycoplasma gallisepticum, avian influenza (H9 subtype), bursal virus disease and otherdiseases, and can effectively kill animal pathogenic bacterias such as cattle colon bacillus, mycoplasma gallisepticum, chicken colibacillosis, etc.

Description

technical field

[0001] The invention relates to the application of citric acid in pharmacy, in particular to the application of a citric acid compound in resisting bursal disease and respiratory diseases caused by livestock and poultry viruses or bacteria. Background technique

[0002] In recent years, as the safety of animal products has attracted more and more attention from consumers, the production of pollution-free animal products has become an inevitable trend in the development of animal husbandry. Developed countries are becoming more and more strict with the registration and management of veterinary drugs. The European Union announced in 2006 that antibiotics would no longer be used as production-promoting additives, and many veterinary drugs were banned. Several types of green additives such as enzymes, prebiotics, and Chinese herbal medicines have become the focus of veterinary drug manufacturers. In particular, the new veterinary drug products with low residue a...

Examples

Embodiment 1

[0034] The compound citric acid of the invention comprises the following components: 94.5 grams of citric acid, 3.0 grams of guaifenesin, and 2.5 grams of sulfoethylamine. Its preparation process is as follows:

[0035] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 2

[0037] The compound citric acid of the present invention comprises the following components: 93 grams of citric acid, 4 grams of guaifenesin, and 3 grams of sulfoethylamine.

[0038] Its preparation process is as follows:

[0039] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 3

[0041] The compound citric acid of the present invention comprises the following components: 97.5 grams of citric acid, 1 gram of guaifenesin, and 1.5 grams of sulfoethylamine.

[0042] Its preparation process is as follows:

[0043] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

[0044] The compound citric acid powder used in the following experimental example is the compound citric acid powder obtained in Example 1.

technical field

[0001] The invention relates to the application of citric acid in pharmacy, in particular to the application of a citric acid compound in resisting bursal disease and respiratory diseases caused by livestock and poultry viruses or bacteria. Background technique

[0002] In recent years, as the safety of animal products has attracted more and more attention from consumers, the production of pollution-free animal products has become an inevitable trend in the development of animal husbandry. Developed countries are becoming more and more strict with the registration and management of veterinary drugs. The European Union announced in 2006 that antibiotics would no longer be used as production-promoting additives, and many veterinary drugs were banned. Several types of green additives such as enzymes, prebiotics, and Chinese herbal medicines have become the focus of veterinary drug manufacturers. In particular, the new veterinary drug products with low residue a...

Examples

Embodiment 1

[0034] The compound citric acid of the invention comprises the following components: 94.5 grams of citric acid, 3.0 grams of guaifenesin, and 2.5 grams of sulfoethylamine. Its preparation process is as follows:

[0035] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 2

[0037] The compound citric acid of the present invention comprises the following components: 93 grams of citric acid, 4 grams of guaifenesin, and 3 grams of sulfoethylamine.

[0038] Its preparation process is as follows:

[0039] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

Embodiment 3

[0041] The compound citric acid of the present invention comprises the following components: 97.5 grams of citric acid, 1 gram of guaifenesin, and 1.5 grams of sulfoethylamine.

[0042] Its preparation process is as follows:

[0043] Each component is weighed according to the above weight, pulverized and passed through an 80-mesh sieve, mixed evenly, and divided into bottles to obtain powder.

[0044] The compound citric acid powder used in the following experimental example is the compound citric acid powder obtained in Example 1.

Images